期刊文献+

慢性房颤患者血清ANP和BNP水平及其临床意义分析 被引量:2

原文传递
导出
摘要 目的:研究慢性房颤(AF)患者血清中心房利钠肽(ANP)和脑利钠肽(BNP)水平的变化及其临床意义。方法:采用放射免疫方法测定98例有AF的心脏疾病患者(AF组)、40例无AF的心脏疾病患者(无AF组)和30例健康对照者(对照组)血清ANP和BNP水平,并进行统计分析。结果:AF组血清ANP和BNP水平均显著高于无AF组和对照组(P均<0.01);无AF组血清BNP水平显著高于对照组(P<0.01),但血清ANP水平与对照组无显著差异(P>0.05);AF组血清ANP水平与BNP水平呈显著正相关(P<0.01),而且AF组患者血清ANP和BNP水平随心功能分级的提高而显著递增(P<0.01)。结论:AF患者血清ANP和BNP水平显著增高,并随心功能分级依次递增。
出处 《中国冶金工业医学杂志》 2009年第4期380-381,共2页 Chinese Medical Journal of Metallurgical industry
  • 相关文献

参考文献3

二级参考文献17

  • 1Matsuura A, Yamochi W, Hirata K, et al. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression[J].Hypertension, 1998,32: 89-95.
  • 2Pedersen OD, Bagger H, Kober L,et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J]. Circulation, 1999,100: 376-380.
  • 3Madrid AH,Bueno MG,Rebollo Jose MG,et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study[J]. Circulation,2002,106: 331-336.
  • 4Danish Li ,Shinagawa K ,Pang Li ,et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogswith ventricular tachypacing-induced congestive heart failure[J]. Circulation, 2001,104 : 2608-2614.
  • 5Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat [J]. Circulation, 1997,96 : 3157-3163.
  • 6Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al.Atrial fibrillation begets atrial fibrillation: A study in awake chronically in strumented goats [J]. Circulation, 1995,92 : 1954-1968,.
  • 7Kanapuli SP,Kumar A. Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart[J]. Circ Res,1987,6:786-790.
  • 8Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation [J]. Biol Chem,1998,273 : 4883-4891.
  • 9Struthers AD. Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart[J]. Card Fai1,1996,7:47-54.
  • 10Weber KT. Pathological hypertrophy and cardiacinterstium:fibrosis and renin-angiotensin-aldosteron esystem[J]. Circulation, 1991,83 : 1849-1851.

共引文献48

同被引文献12

  • 1王丽丽,龙娟,徐验,衣为民.血浆脑利钠肽与房颤病人复律和复发的临床研究[J].中西医结合心脑血管病杂志,2007,5(4):320-321. 被引量:1
  • 2Wijffels MC,Kirchhof CJ,Dorland R,et al.Atrial fibrillation begetsatrial fibrillation.A study in awake chronically in strumented goats[J].Circulation,1995,92(7):1954-1968.
  • 3de Denus S,Pharand C,Williamson DR.William son Brain natri-uretic peptide in the management of heart failure:the versatile neu-rohormone[J].Chest,2004,125(2):652-668.
  • 4Asselbergs FW,van den Berg MP,Bakker SJ,et al.N-terminal proB-type natriuretic peptide levels predict newly detected atrial fibril-lation in a population-based cohort[J].Neth Heart J,2008,16(3):73-78.
  • 5Struthers A,Lang C.The potential to improve primary prevention inthe future by using BNP/N-BNP as an indicator of silent'pancardi-ac'target organ damage[J].Eur Heart J,2007,28(14):1678-1682.
  • 6Bagnall AJ,Kelland NF,Gulliver-Sloan F,et al.Deletion of endo-thelial cell endothelin b receptors does not affect blood pressure orsensitivity to salt[J].Clin Sci,2000,98(1):65-70.
  • 7Conway DS,Pearce LA,Chin BS,et al.Prognostic Value of plasmavon willebrand factor and soluble P-selectin as indices of endotheli-al damage and platelet activation in 994 patients with nonvalvularatrial fibrillation[J].Circulation,2003,107(25):3141-3145.
  • 8Maas R,Schwedhelm E,Albsmeier J,et al.The pathophysiology oferectile dysfunction related to endothelial dysfunction and media-tors of vascular function[J].Vasc Med,2002,7(3):213-225.
  • 9Kumagai K,Nakashima H,Saku K,et al.The HMG-CoA reductaseinhibitor atorvastatin prevents atrial fibrillation by inhibiting in-flammation in a canine sterile pericarditis model[J].CardiovascRes,2004,62(1):105-111.
  • 10Mitu O,Mitu F,Constantin S,et al.Therapeutical considerations in associated atrial fibrillation and heart failure[J].Rev Med Chir Soc Med Nat Iasi,2014,118(3):624-630.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部